New Single Dose Vaccine Shows Protection Against COVID-19: S
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Belgium virologists have developed a vaccine candidate against Covid-19 based on the yellow fever vaccine which showed that the it protects hamsters and monkeys from infection with the SARS-CoV-2 coronavirus after a single dose.

While developing the RegaVax vaccine the team inserted the genetic code of the SARS-CoV-2 spikes into the genetic code of the yellow fever vaccine. It was tested in healthy hamsters and monkeys. Another group received a placebo.

The authors stated in some monkeys neutralising antibodies were observed after seven days of vaccination and the virus was completely or nearly completely gone from their throats.

RegaVax works after one dose and the team expects that the vaccine will offer long-lasting immunity to Covid-19, the vaccine can be stored at 2-8 degree Celsius.

The team is now preparing for clinical trials next year and has joined forces with a specialised and accredited company that will produce the vaccine candidate for testing in humans.

Source:
https://health.economictimes.indiatimes.com/news/diagnostics/belgium-vax-candidate-protects-against-covid-19-study/79527146
1 share
Like
Comment
Share